Plus Therapeutics Launches ReSPECT Clinical Trial Website for Patients with Recurrent Glioblastoma from rhenium re Watch Video
Preview(s): Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: The purpose of the ReSPECT Clinical Trial is to assess the safety, tolerability, and distribution of a new medication, Rhenium NanoLiposome (RNL™), in adults with recurrent or progressive malignant glioma after standard surgical, radiation, and/or chemotherapy treatment.ReSPECT is supported by the National Institutes of Health / National Cancer Institute.nnNATIONAL TRIAL REFERENCE NUMBER:NCT01906385nWhen speaking with your physician, please have the national trial reference number availabl